BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17959753)

  • 1. Promoter methylation is associated with the age-dependent loss of N-cadherin in the rat kidney.
    Akintola AD; Crislip ZL; Catania JM; Chen G; Zimmer WE; Burghardt RC; Parrish AR
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F170-6. PubMed ID: 17959753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
    Chen Q; Lipkina G; Song Q; Kramer RH
    Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
    Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats.
    Jung KY; Dean D; Jiang J; Gaylor S; Griffith WH; Burghardt RC; Parrish AR
    Mech Ageing Dev; 2004 Jun; 125(6):445-53. PubMed ID: 15178134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications affect Dnmt3L expression.
    Aapola U; Mäenpää K; Kaipia A; Peterson P
    Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
    Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
    Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aberrant methylation of T-cadherin gene in human esophageal carcinoma cells].
    Jing Z; Zou CL; Li G; Deng X; Wu SX
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(37):2653-6. PubMed ID: 22321935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
    Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
    Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
    Ladd PD; Butler JS; Skalnik DG
    Gene; 2004 Oct; 341():323-33. PubMed ID: 15474314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H; Babcock K; Pitot HC
    Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy.
    Ran Y; Wu S; You Y
    J Biochem; 2011 Jan; 149(1):49-54. PubMed ID: 21059597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.